Literature DB >> 17086174

SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination.

Moon Hee Lee1, Sung Won Lee, Eun Joo Lee, Soo Joon Choi, Sung Soo Chung, Jae Il Lee, Joong Myung Cho, Jae Hong Seol, Sung Hee Baek, Keun Il Kim, Tomoki Chiba, Keiji Tanaka, Ok Sun Bang, Chin Ha Chung.   

Abstract

The p53 tumour suppressor has a key role in the control of cell growth and differentiation, and in the maintenance of genome integrity. p53 is kept labile under normal conditions, but in response to stresses, such as DNA damage, it accumulates in the nucleus for induction of cell-cycle arrest, DNA repair or apoptosis. Mdm2 is an ubiquitin ligase that promotes p53 ubiquitination and degradation. Mdm2 is also self-ubiquitinated and degraded. Here, we identified a novel cascade for the increase in p53 level in response to DNA damage. A new SUMO-specific protease, SUSP4, removed SUMO-1 from Mdm2 and this desumoylation led to promotion of Mdm2 self-ubiquitination, resulting in p53 stabilization. Moreover, SUSP4 competed with p53 for binding to Mdm2, also resulting in p53 stabilization. Overexpression of SUSP4 inhibited cell growth, whereas knockdown of susp4 by RNA interference (RNAi) promoted of cell growth. UV damage induced SUSP4 expression, leading to an increase in p53 levels in parallel with a decrease in Mdm2 levels. These findings establish a new mechanism for the elevation of cellular p53 levels in response to UV damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086174     DOI: 10.1038/ncb1512

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  25 in total

1.  Overexpression of SUMO-1 in hepatocellular carcinoma: a latent target for diagnosis and therapy of hepatoma.

Authors:  Wu-Hua Guo; Li-Hua Yuan; Zhi-Hua Xiao; Dan Liu; Ji-Xiang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-26       Impact factor: 4.553

2.  SUMO E3 ligase activity of TRIM proteins.

Authors:  Y Chu; X Yang
Journal:  Oncogene       Date:  2010-10-25       Impact factor: 9.867

3.  SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells.

Authors:  Jung Hwa Kim; Ji Min Lee; Hye Jin Nam; Hee June Choi; Jung Woo Yang; Jason S Lee; Mi Hyang Kim; Su-Il Kim; Chin Ha Chung; Keun Il Kim; Sung Hee Baek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

4.  Control of adipogenesis by the SUMO-specific protease SENP2.

Authors:  Sung Soo Chung; Byung Yong Ahn; Min Kim; Hye Hun Choi; Ho Seon Park; Shinae Kang; Sang Gyu Park; Young-Bum Kim; Young Min Cho; Hong Kyu Lee; Chin Ha Chung; Kyong Soo Park
Journal:  Mol Cell Biol       Date:  2010-03-01       Impact factor: 4.272

5.  DeSUMOylating isopeptidase: a second class of SUMO protease.

Authors:  Eun Ju Shin; Hyun Mi Shin; Eori Nam; Won Seog Kim; Ji-Hoon Kim; Byung-Ha Oh; Yungdae Yun
Journal:  EMBO Rep       Date:  2012-04       Impact factor: 8.807

6.  Degringolade, a SUMO-targeted ubiquitin ligase, inhibits Hairy/Groucho-mediated repression.

Authors:  Mona Abed; Kevin C Barry; Dorit Kenyagin; Bella Koltun; Taryn M Phippen; Jeffrey J Delrow; Susan M Parkhurst; Amir Orian
Journal:  EMBO J       Date:  2011-02-22       Impact factor: 11.598

Review 7.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

8.  cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.

Authors:  Rosanna Lau; Min Ying Niu; M A Christine Pratt
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

9.  SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.

Authors:  Seong Won Lee; Moon Hee Lee; Jong Ho Park; Sung Hwan Kang; Hee Min Yoo; Seung Hyun Ka; Young Mi Oh; Young Joo Jeon; Chin Ha Chung
Journal:  EMBO J       Date:  2012-10-23       Impact factor: 11.598

Review 10.  Ubiquitin proteolytic system: focus on SUMO.

Authors:  Van G Wilson; Phillip R Heaton
Journal:  Expert Rev Proteomics       Date:  2008-02       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.